Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
The defect of B cell development in CD19-Cre + PDK1 flox/flox mice is... | Download Scientific Diagram
Percentages of CD4 + IL10 + T cells and CD19 + IL10 + B cells increase,... | Download Scientific Diagram
CD19 Monoclonal Antibody (eBio1D3 (1D3)), PerCP-Cyanine5.5 (45-0193-82)
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab | Haematologica
CAR T Cell Immunotherapy Beyond Haematological Malignancy
Cells | Free Full-Text | Flow Cytometric Methods for the Detection of Intracellular Signaling Proteins and Transcription Factors Reveal Heterogeneity in Differentiating Human B Cell Subsets
15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges - Chatterjee ...
CD19 Monoclonal Antibody (SJ25-C1), PE-Alexa Fluor™ 610 (MHCD1922)
Frontiers | Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy
Normal B-cell ranges in infants: A systematic review and meta-analysis - ScienceDirect
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies - ScienceDirect
Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia - Soma - 2015 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes - ScienceDirect
ExCellerate B Cell Media, Xeno-Free (CCM031): R&D Systems®
CD19 Monoclonal Antibody (eBio1D3 (1D3)), PerCP-Cyanine5.5 (45-0193-82)
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
Characteristics of iKP-19-CAR-T cells and CD19-CAR-T cells.... | Download Scientific Diagram
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
Antibodies | Free Full-Text | Cutaneous Lymphoma and Antibody-Directed Therapies
